Abstract

Since the global withdrawal of Sabin 2 oral poliovirus vaccine (OPV) from routine immunization, the Global Polio Eradication Initiative (GPEI) has reported multiple circulating vaccine-derived poliovirus type 2 (cVDPV2) outbreaks. Here, we generated an agent-based, mechanistic model designed to assess OPV-related vaccine virus transmission risk in populations with heterogeneous immunity, demography, and social mixing patterns. To showcase the utility of our model, we present a simulation of mOPV2-related Sabin 2 transmission in rural Matlab, Bangladesh based on stool samples collected from infants and their household contacts during an mOPV2 clinical trial. Sabin 2 transmission following the mOPV2 clinical trial was replicated by specifying multiple, heterogeneous contact rates based on household and community membership. Once calibrated, the model generated Matlab-specific insights regarding poliovirus transmission following an accidental point importation or mass vaccination event. We also show that assuming homogeneous contact rates (mass action), as is common of poliovirus forecast models, does not accurately represent the clinical trial and risks overestimating forecasted poliovirus outbreak probability. Our study identifies household and community structure as an important source of transmission heterogeneity when assessing OPV-related transmission risk and provides a calibratable framework for expanding these analyses to other populations.Trial Registration: ClinicalTrials.gov This trial is registered with clinicaltrials.gov, NCT02477046.

Highlights

  • Mass immunization with the live-attenuated oral poliovirus vaccines (OPV) have successfully reduced wild poliovirus (WPV) incidence by 99% and resulted in the eradication of two of the three poliovirus serotypes (Type 1 and Type 2) [1,2,3]

  • We generated and calibrated a poliovirus transmission model that combines multigenerational household and community structure, intrahost infection, and immunity modeling to shedding data collected during a monovalent Sabin 2 OPV clinical trial performed in Matlab, Bangladesh

  • Our study shows that household and community structure plays an important role in limiting poliovirus transmission and that its inclusion in transmission model is necessary for accurate outbreak risk prediction

Read more

Summary

Introduction

Mass immunization with the live-attenuated oral poliovirus vaccines (OPV) have successfully reduced wild poliovirus (WPV) incidence by 99% and resulted in the eradication of two of the three poliovirus serotypes (Type 1 and Type 2) [1,2,3]. Complete poliovirus eradication must include the three OPV vaccine viruses (Sabin 1, 2, and 3), which are transmissible and capable of reverting attenuation. Circulating, vaccine-derived poliovirus (cVDPV) can cause clinical poliomyelitis cases indistinguishable from those of WPV [4,5] and is a rapidly growing public health threat. The GPEI (Global Polio Eradication Initiative) is caught in a paradoxical situation because the current cVDPV2 containment strategy relies on immunization with monovalent Sabin 2 OPV (mOPV2) [6,7]. Half of the outbreaks reported in 2019 were traced to a previous mOPV2 vaccination campaign [8]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call